NKTR
Nektar TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NKTR Profile
Nektar Therapeutics
A biopharmaceutical company that developing investigational medicines in oncology, immunology, and inflammatory diseases
455 Mission Bay Boulevard South, San Francisco, California 94158
--
Nektar Therapeutics was founded in California in 1990 and re-registered in Delaware in 1998. The company is a clinical-stage, investigational drug discovery biopharmaceutical company focused on the discovery and development of innovative drugs in the field of immunotherapy. In this growing field, the company is committed to creating new immunomodulators that selectively induce, amplify, attenuate or block immune responses to achieve the desired therapeutic effect.
